Flaviana Amarante — Bayer (United Kingdom)

Area of research

Cardiology and Cardiovascular Medicine · Endocrinology, Diabetes and Metabolism

Research interest

Research interests include Heart Failure Treatment and Management, Hormonal Regulation and Hypertension, Cardiovascular Function and Risk Factors, and Pulmonary Hypertension Research and Treatments.

Recent publications

Finerenone and new-onset diabetes in heart failure: a prespecified analysis of the FINEARTS-HF trial

The Lancet Diabetes & Endocrinology 2025cited by 17position: middledoi

Finerenone and Atrial Fibrillation in Heart Failure

JAMA Cardiology 2025cited by 15position: middledoi

Effects of Finerenone on Natriuretic Peptide Levels in Heart Failure with Mildly Reduced or Preserved Ejection Fraction: The FINEARTS-HF Trial

European Journal of Heart Failure 2025cited by 12position: middledoi

Finerenone in Heart Failure With Improved Ejection Fraction

JAMA Cardiology 2025cited by 11position: middledoi

The Efficacy of Finerenone on Hierarchical Composite Endpoint Analysed Using Win Statistics in Patients with Heart Failure and Mildly Reduced or Preserved Ejection Fraction: A Prespecified Analysis of FINEARTS-HF

European Journal of Heart Failure 2025cited by 9position: middledoi

Baseline Characteristics of Patients with Heart Failure with Mildly Reduced or Preserved Ejection Fraction: The FINEARTS-HF Trial

European Journal of Heart Failure 2024cited by 60position: middledoi

Finerenone in Patients With a Recent Worsening Heart Failure Event

Journal of the American College of Cardiology 2024cited by 36position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

Looking for a research collaborator?

Search millions of scientists by field, institution, impact, and funding status — see their work, find their email, and reach out directly.

Find collaborators in Cardiology and Cardiovascular Medicine · Endocrinology, Diabetes and Metabolism →